Applied StemCell

At Applied StemCell, we know that consistent, high-quality materials are the backbone of successful stem cell research. With over 15 years of experience in IPSC research and development, we've refined our methods to ensure that these MEF feeder cells meet the strictest standards for performance and reliability. Our MEF feeder cells provide an ideal microenvironment for your stem cell cultures, supporting stable pluripotency and long-term growth. Whether you’re working on basic research or developing novel therapies, our feeder cells are an essential tool to help drive your project forward. Why Choose Applied StemCell's MEF Feeder Cells? - High-quality, consistency-tested cells used in our labs - Optimized to support stable, high-yield iPSC growth - Backed by over a decade of expertise in stem cell research - Available in both mitomycin-treated and irradiated formats Purchase today and experience firsthand why so many researchers rely on Applied StemCell’s MEF feeder cells to achieve reproducible and successful outcomes. Let our experience power your discoveries! Learn more: https://lnkd.in/gDtgaKkA

ONLINE EVENT ALERT! We are happy to co-sponsor this year’s Cell & Gene Therapy Showcase, a free online event that will outline areas of opportunity in the CGT drug discovery and development sector and highlight challenges facing the industry and how they can be overcome. Register here: https://lnkd.in/gXnVqcmh?

Day 2 at SITC 2024 – Connect with Applied StemCell! We’re here at SITC 2024, and it’s been an incredible start! Visit Booth 635 to continue exploring how our TARGATT? gene editing technology is paving the way in immunotherapy and antibody discovery. Today at Booth 635: - Learn how TARGATT? supports precise, site-specific gene integration for stable cell lines and high-efficiency antibody screening. - Chat with our experts, Heather Lundie and Wesley Chen, about customized solutions to meet your research needs. - Discover the latest innovations for accelerating immuno-oncology projects with our robust cell engineering platforms. Let’s make today all about innovation and collaboration! Stop by Booth 635 to connect with us and explore new possibilities for your research!

Day 1 at SITC 2024 – Come Visit Applied StemCell! We’re excited to kick off Day 1 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting! Stop by Booth 635 to meet Heather Lundie and Wesley Chen and explore how our TARGATT? technology is driving advancements in immuno-oncology. Here’s what’s happening at our booth today: - Discover how TARGATT? enables precise gene editing for enhanced antibody discovery and cell line development. -? Learn about our customizable solutions for antibody screening and cell engineering tailored to your research needs.? - Chat with our team about collaborative opportunities to accelerate your projects! ?? Location: Booth 635? ?? Today, November 8-10 We’re here to make connections and inspire breakthroughs in immunotherapy research. Come by Booth 635 – we’d love to meet you!

?? New eBook Alert: TARGATT? Unique Technology for Antibody Discovery and Screening Applied StemCell’s latest eBook delves into the power of our TARGATT? technology and how it allows for an irreversible, site-specific gene insertion at a safe-harbor locus. This comprehensive resource covers how our site-specific gene integration supports the creation of robust, stable cell lines and single copy insertion. Why TARGATT?? Our proprietary technology enhances the efficiency and consistency of antibody engineering, paving the way for innovations in therapeutic development. ?? Download now to explore how TARGATT? can transform your research process! https://lnkd.in/gCkGPtGY

Join Applied StemCell at SITC 2024! We’re excited to announce that Applied StemCell will be at SITC 2024 in Houston! Visit us at Booth 635 to explore our latest innovations and how we enable immunotherapy research. From building relevant cell and rodent disease models to creating ideal cell lines for screening antibody-based therapeutics in human cells, Applied StemCell is ready to power your immunotherapy studies. ?? Meet the Team: Don’t miss the chance to connect with our experts, Heather Lundie and Wesley Chen. They’ll be available to discuss how Applied StemCell can support your research goals with customized solutions in immuno-oncology and beyond. Whether you're interested in our advanced gene editing services or our comprehensive suite of preclinical models, stop by Booth 635 to learn more! ?? Where: SITC 2024, Booth 635? ?? When: November 8-10 We’ll see you there!

We are excited about being part of the Alliance of Regenerative Medicine, a great organization dedicated to advancing cell and gene therapies. We look forward to contributing to their work, shaping policy, and ensuring access to the future of medicine. To learn more, visit https://alliancerm.org/.?

For those looking to scale up screening with NK Cells or enhance consistency in their NK cell research, Applied StemCell is now offering a limited-time 20% discount on our iPSC-derived NK cells. These high-purity cells are available in different backgrounds and optimized for research needs and allogeneic cell therapy discovery. Each vial includes ≥1 x 10? cells at ≥80% purity, backed by quality control and powerful tumor-killing functionality. ?? Learn more about this offer and get your NK cell kit today: https://lnkd.in/gmKE6mmB

Breakthrough in Allogeneic Cell Therapy: Overcoming Immune System Rejection ?? In the world of allogeneic cell therapy, a major challenge has been generating donor cells that can persist in a host without triggering immune rejection. Simply knocking out HLA molecules on donor cells doesn't cut it—without self-recognition signals, NK cells target these cells for destruction. Applied StemCell’s latest patented technology addresses this problem. By expressing a non-canonical HLA class 1b molecule, we’re enabling donor cells to evade the host immune system, marking a critical step forward in allogeneic cell therapy development. Want to learn more about our approach? Join us for an exclusive webinar featuring our CEO, Ruby Tsai, PhD, to dive into the science behind this game-changing technology. Register Now to Discover the Future of Cell Therapy https://lnkd.in/gu4UfG_Q

Harness the power of iPSC-derived NK cells for immunotherapy research and more! Ideal for basic research, drug screening, and cell therapy development, our high-quality P0 iPSC-derived NK cells are 20% off for a limited time! iPSC-derived NK cells are available in two backgrounds from healthy donors. ASE-9285-3?cells are derived from ASE-9250 iPSC cells, which have a matching GMP line for cell therapy development. Take your research to the next level with high-quality iPSC-derived NK cells! Start here ? https://bit.ly/48kagLe